Original Research
Published on 19 Oct 2022
A novel twelve-gene signature to predict neoadjuvant chemotherapy response and prognosis in breast cancer
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2022.1035667
- 6,572 views
- 6 citations

